These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24009132)

  • 21. Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma.
    Nielsen T; Kristensen SR; Gregersen H; Teodorescu EM; Christiansen G; Pedersen S
    PLoS One; 2019; 14(1):e0210835. PubMed ID: 30640949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin generation and procoagulant microparticle profiles after acute trauma: A prospective cohort study.
    Park MS; Xue A; Spears GM; Halling TM; Ferrara MJ; Kuntz MM; Dhillon SK; Jenkins DH; Harmsen WS; Ballman KV; Harrison P; Heit JA
    J Trauma Acute Care Surg; 2015 Nov; 79(5):726-31. PubMed ID: 26496097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular microparticle and thrombogram phenotypes in the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study: correlation with coagulopathy.
    Matijevic N; Wang YW; Wade CE; Holcomb JB; Cotton BA; Schreiber MA; Muskat P; Fox EE; Del Junco DJ; Cardenas JC; Rahbar MH; Cohen MJ;
    Thromb Res; 2014 Sep; 134(3):652-8. PubMed ID: 25086657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extrinsic blood coagulation pathway and risk factors for thrombotic events in patients with essential thrombocythemia.
    Stankowska K; Gadomska G; Boinska J; Michalska M; Bartoszewska-Kubiak A; Rość D
    Pol Arch Med Wewn; 2016 May; 126(5):340-6. PubMed ID: 27243342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women.
    Radu CM; Campello E; Spiezia L; Dhima S; Visentin S; Gavasso S; Woodhams B; Cosmi E; Simioni P
    Scand J Clin Lab Invest; 2015 Oct; 75(6):487-95. PubMed ID: 26067611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.
    Arellano-Rodrigo E; Alvarez-Larrán A; Reverter JC; Colomer D; Villamor N; Bellosillo B; Cervantes F
    Am J Hematol; 2009 Feb; 84(2):102-8. PubMed ID: 19105233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft Product for Autologous Peripheral Blood Stem Cell Transplantation Enhances Thrombin Generation and Expresses Procoagulant Microparticles and Tissue Factor.
    Sidibe F; Spanoudaki A; Vanneaux V; Mbemba E; Larghero J; Van Dreden P; Lotz JP; Elalamy I; Larsen AK; Gerotziafas GT
    Clin Appl Thromb Hemost; 2018 May; 24(4):684-690. PubMed ID: 28681632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Level of Microparticles in Patients with Essential Thrombocythemia and Its Relation with JAK2V617F Mutation].
    Zhao SX; Yang TH; Pei Q; Zhao RB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2046-2050. PubMed ID: 33283740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls.
    Hellum M; Franco-Lie I; Øvstebø R; Hauge T; Henriksson CE
    PLoS One; 2017; 12(9):e0184579. PubMed ID: 28910348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating microparticles in carriers of prothrombin G20210A mutation.
    Campello E; Spiezia L; Radu CM; Gavasso S; Zerbinati P; Woodhams B; Simioni P
    Thromb Haemost; 2014 Sep; 112(3):432-7. PubMed ID: 24816676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol.
    Lacroix R; Judicone C; Poncelet P; Robert S; Arnaud L; Sampol J; Dignat-George F
    J Thromb Haemost; 2012 Mar; 10(3):437-46. PubMed ID: 22212198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock.
    Hellum M; Øvstebø R; Brusletto BS; Berg JP; Brandtzaeg P; Henriksson CE
    Thromb Res; 2014 Mar; 133(3):507-14. PubMed ID: 24423888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers.
    Treliński J; Wierzbowska A; Krawczyńska A; Sakowicz A; Pietrucha T; Smolewski P; Robak T; Chojnowski K
    Int J Hematol; 2010 Jun; 91(5):792-8. PubMed ID: 20473593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphonuclear neutrophils from JAK2(V617F) positive MPD patients do not support hypercoagulability: A study with calibrated automated thrombography (CAT).
    Perrin J; Ranta D; Empereur F; Vigneron C; Feugier P; Lecompte T
    Blood Cells Mol Dis; 2011 Mar; 46(3):235-8. PubMed ID: 21306925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer.
    Rousseau A; Van Dreden P; Khaterchi A; Larsen AK; Elalamy I; Gerotziafas GT
    Int J Oncol; 2017 Dec; 51(6):1793-1800. PubMed ID: 29075792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera.
    Marchetti M; Castoldi E; Spronk HM; van Oerle R; Balducci D; Barbui T; Rosing J; Ten Cate H; Falanga A
    Blood; 2008 Nov; 112(10):4061-8. PubMed ID: 18768782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: role in increased thrombin generation.
    Deutschmann A; Schlagenhauf A; Leschnik B; Hoffmann KM; Hauer A; Muntean W
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):401-7. PubMed ID: 23164759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the absence of JAK2 mutation a risk factor for bleeding in essential thrombocythemia? An analysis of 106 patients.
    Patriarca A; Pompetti F; Malizia R; Iuliani O; Di Marzio I; Spadano A; Dragani A
    Blood Transfus; 2010 Jan; 8(1):21-7. PubMed ID: 20104275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections.
    Woei-A-Jin FJ; van der Starre WE; Tesselaar ME; Garcia Rodriguez P; van Nieuwkoop C; Bertina RM; van Dissel JT; Osanto S
    Thromb Res; 2014 May; 133(5):799-803. PubMed ID: 24657035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.